Evidence-Based Drug Policy Act of 2025

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Apr 29, 2025

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Actions (5)

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Type: IntroReferral | Source: House floor actions | Code: H11100

Apr 29, 2025

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Type: IntroReferral | Source: House floor actions | Code: H11100

Apr 29, 2025

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Type: IntroReferral | Source: House floor actions | Code: H11100

Apr 29, 2025

Introduced in House

Type: IntroReferral | Source: Library of Congress | Code: Intro-H

Apr 29, 2025

Introduced in House

Type: IntroReferral | Source: Library of Congress | Code: 1000

Apr 29, 2025

Subjects (1)

Crime and Law Enforcement (Policy Area)

Cosponsors (1)

Rep. Omar, Ilhan [D-MN-5]

(D-MN)
Apr 29, 2025

Text Versions (1)

Introduced in House

Apr 29, 2025

PDF ↗ XML ↗

Full Bill Text

Length: 1,576 characters Version: Introduced in House Version Date: Apr 29, 2025 Last Updated: Nov 13, 2025 6:34 AM

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3082 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. R. 3082

To repeal

section 704 (b) (12) of the Office of National Drug Control Policy Reauthorization Act of 1998, and for other purposes.

(b)

(12) of the Office of National Drug Control
Policy Reauthorization Act of 1998, and for other purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

April 29, 2025

Ms. Titus (for herself and Ms. Omar) introduced the following bill;
which was referred to the Committee on Oversight and Government Reform,
and in addition to the Committees on Energy and Commerce, and the
Judiciary, for a period to be subsequently determined by the Speaker,
in each case for consideration of such provisions as fall within the
jurisdiction of the committee concerned

_______________________________________________________________________

A BILL

To repeal

section 704 (b) (12) of the Office of National Drug Control Policy Reauthorization Act of 1998, and for other purposes.

(b)

(12) of the Office of National Drug Control
Policy Reauthorization Act of 1998, and for other purposes.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1.

This Act may be cited as the ``Evidence-Based Drug Policy Act of
2025''.

SEC. 2.

SECTION 704 (B) (12) OF THE OFFICE OF NATIONAL DRUG CONTROL POLICY REAUTHORIZATION ACT OF 1998.

(B) (12) OF THE OFFICE OF NATIONAL DRUG
CONTROL POLICY REAUTHORIZATION ACT OF 1998.

Section 704 (b) (12) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.

(b)

(12) of the Office of National Drug Control Policy
Reauthorization Act of 1998 (21 U.S.C. 1703

(b)

(12) ) is repealed.
<all>

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3082 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 3082

 To repeal 

section 704

    (b)

    (12) of the Office of National Drug Control 
 Policy Reauthorization Act of 1998, and for other purposes.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 April 29, 2025

 Ms. Titus (for herself and Ms. Omar) introduced the following bill; 
which was referred to the Committee on Oversight and Government Reform, 
 and in addition to the Committees on Energy and Commerce, and the 
 Judiciary, for a period to be subsequently determined by the Speaker, 
 in each case for consideration of such provisions as fall within the 
 jurisdiction of the committee concerned

_______________________________________________________________________

 A BILL

 To repeal 

section 704

    (b)

    (12) of the Office of National Drug Control 
 Policy Reauthorization Act of 1998, and for other purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Evidence-Based Drug Policy Act of 
2025''.

SEC. 2. REPEAL OF 

SECTION 704
        (B) (12) OF THE OFFICE OF NATIONAL DRUG 
 CONTROL POLICY REAUTHORIZATION ACT OF 1998.

 

Section 704

    (b)

    (12) of the Office of National Drug Control Policy 
Reauthorization Act of 1998 (21 U.S.C. 1703

    (b)

    (12) ) is repealed.
 <all>

View original source ↗

119-hr3082